{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:24:08Z","timestamp":1787729048762,"version":"build-2784847793"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1007\/bf00279977","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T14:31:27Z","timestamp":1653057087000},"page":"599-601","source":"Crossref","is-referenced-by-count":19,"title":["Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia"],"prefix":"10.1007","volume":"40","author":[{"given":"P.","family":"Lafolie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hayder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF00279977_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V56.1.1.1","volume":"56","author":"AM Mauer","year":"1980","unstructured":"Mauer AM (1980) Therapy of acute lymphoblastic leukemia. Blood 56: 1\u201310","journal-title":"Blood"},{"key":"BF00279977_CR2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0031-3955(16)34831-3","volume":"32","author":"DG Poplack","year":"1985","unstructured":"Poplack DG (1985) Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am 32: 669\u2013697","journal-title":"Pediatr Clin North Am"},{"key":"BF00279977_CR3","first-page":"898","volume":"26","author":"G Elion","year":"1967","unstructured":"Elion G (1967) Biochemistry and pharmacology of purine analogs. Fed Proc 26: 898\u2013903","journal-title":"Fed Proc"},{"key":"BF00279977_CR4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM198304283081705","volume":"308","author":"S Zimm","year":"1983","unstructured":"Zimm S, Collins JM, Riccardi R, O'Neill D, Narang P, Chabner B, Poplack DG (1983) Variable bioavailability of oral mercaptopurine: Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med 308: 1005\u20131009","journal-title":"N Engl J Med"},{"key":"BF00279977_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08880018609031198","volume":"3","author":"G L\u00f6nnerholm","year":"1986","unstructured":"L\u00f6nnerholm G, Lindstr\u00f6m B, Ludvigsson J, Myrdal U (1986) Plasma and erythrocyte concentrations after oral administration in children. Pediatr Hematol Oncol 3: 27\u201335","journal-title":"Pediatr Hematol Oncol"},{"key":"BF00279977_CR6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1651-2227.1986.tb10293.x","volume":"75","author":"P Lafolie","year":"1986","unstructured":"Lafolie P, Hayder S, Bj\u00f6rk O, \u00c5hstr\u00f6m L, Liliemark J, Peterson C (1986) Large inter-individual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukemia and non-Hodgkin lymphoma. Acta Pediatr Sand 75: 797\u2013803","journal-title":"Acta Pediatr Sand"},{"key":"BF00279977_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00007691-198911000-00001","volume":"11","author":"S Hayder","year":"1989","unstructured":"Hayder S, Lafolie P, Bj\u00f6rk O, Peterson C (1989) 6-mercaptopurine plasma levels in children with acute lymphoblastic leukemia: Relation to relapse risk and myelotoxicity. Ther Drug Monit 11: 617\u2013622","journal-title":"Ther Drug Monit"},{"key":"BF00279977_CR8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/000456328802500505","volume":"25","author":"JL Rudy","year":"1988","unstructured":"Rudy JL, Argyle JC, Winick N, Dreal van P (1988) HPLC analysis of 6-mercaptopurine and metabolites in extracellular body fluids. Ann Clin Biochem 25: 504\u2013509","journal-title":"Ann Clin Biochem"},{"key":"BF00279977_CR9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00253074","volume":"18","author":"N Burton","year":"1986","unstructured":"Burton N, Barnett M, Ahearne G, Evans J, Douglas I, Lister T (1986) The effect of food on the oral administration of 6-mercaptopurine. Cancer Chemother Pharmacol 18: 90\u201391","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00279977_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02985158","volume":"6","author":"P Lafolie","year":"1989","unstructured":"Lafolie P, Bj\u00f6rk O, Hayder S, \u00c5hstr\u00f6m L, Peterson C (1989) Variability of 6-mercaptopurine during oral maintenance therapy of children with acute leukemia. Med Oncol Tumor Pharmacother 6: 259\u2013265","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"BF00279977_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/08880018909034276","volume":"6","author":"G L\u00f6nnerholm","year":"1989","unstructured":"L\u00f6nnerholm G, Kreuger A, Lindstr\u00f6m B, Myrdal U (1989) Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability. Pediatr Oncol Hematol 6: 105\u2013112","journal-title":"Pediatr Oncol Hematol"},{"key":"BF00279977_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/08880018609031233","volume":"3","author":"R Riccardi","year":"1986","unstructured":"Riccardi R, Balis FM, Ferrara P, Lasorella A, Poplack DG, Mastrangelo R (1986) Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 3: 319\u2013324","journal-title":"Pediatr Hematol Oncol"},{"key":"BF00279977_CR13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/clpt.1987.45","volume":"41","author":"FM Balis","year":"1987","unstructured":"Balis FM, Holcenberg JS, Zimm S, Tuberger D, Collins JM, Murphy RF, Gildchrist GS, Hammond D, Poplack DG (1987) The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther 41: 384\u2013387","journal-title":"Clin Pharmacol Ther"},{"key":"BF00279977_CR14","first-page":"87","volume":"12","author":"CA Rees","year":"1984","unstructured":"Rees CA, Lennard L, Lilleyman JS, Maddocks JL (1984) Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukemia. Cancer Chemother Pharmacol 12: 87\u201389","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00279977_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/bjc.1986.16","volume":"53","author":"L Lennard","year":"1986","unstructured":"Lennard L, Lilleyman JS, Maddocks JL (1986) The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia. Br J Cancer 53: 115\u2013119","journal-title":"Br J Cancer"},{"key":"BF00279977_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(87)91808-3","volume":"II","author":"A Langevin","year":"1987","unstructured":"Langevin A, Koren G, Soldein S, Greenberg M (1987) Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night. Lancet II: 505\u2013506","journal-title":"Lancet"},{"key":"BF00279977_CR17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(85)91551-X","volume":"II","author":"GE Rivard","year":"1985","unstructured":"Rivard GE, Infante-Rivard C, Hoyoux C, Champagne J (1985) Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: Better in the evening. Lancet II: 1264\u20131266","journal-title":"Lancet"},{"key":"BF00279977_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/1097-0142(19860715)58:2+<473::AID-CNCR2820581311>3.0.CO;2-0","volume":"58","author":"DG Poplack","year":"1986","unstructured":"Poplack DG, Balis FM, Zimm S (1986) The pharmacology of orally administered chemotherapy. A reappraisal. Cancer 58: 473\u2013480","journal-title":"Cancer"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00279977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00279977\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00279977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T14:31:46Z","timestamp":1653057106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00279977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["BF00279977"],"URL":"https:\/\/doi.org\/10.1007\/bf00279977","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}